Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 925-930, September 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giovanella, B. C.
Right arrow Articles by Heidelberger, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giovanella, B. C.
Right arrow Articles by Heidelberger, C.

The Preparation and Purification of Tritiated Carcinogenic Hydrocarbons*

Beppino C. Giovanella, C. W. Abell and Charles Heidelberger{dagger}

( McArdle Memorial Laboratory, Medical School, University of Wisconsin, Madison, Wisconsin)

Methods have been described for the preparation of tritiated carcinogenic polycyclic aromatic hydrocarbons of high specific activity by the Wilzbach method. A large number of highly radioactive impurities were produced during the exposure to tritium gas, and extensive purification was required. This was achieved by column chromatography followed by various paper chromatographic systems with some novel modifications. The following compounds were labeled by this method: 10-methyl-1,2-benzanthracene, 3-methyl-1,2-benzanthracene, 4-methyl-1,2-benzanthracene, 3-fluoro-10-methyl-1,2-benzanthracene, 4-fluoro-10-methyl-1,2-benzanthracene, 1,2,5,6-dibenzanthracene, 1,2,3,4-dibenzanthracene, 9,10-dimethyl-1,2,5,6-dibenzanthracene, 3,4-benzpyrene, 3-methylcholanthrene, 9,10-dimethyl-1,2-benzanthracene, anthanthrene, and 2-phenylphenanthrene-3,2'-dialdehyde.

* This work was supported in part by grants C-1132 and CRTY-5002, from the National Cancer Institute, National Institutes of Health, Public Health Service.

{dagger} American Cancer Society Professor of Oncology.

Received 3/23/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.